1. Home
  2. PRAX vs HRB Comparison

PRAX vs HRB Comparison

Compare PRAX & HRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$305.30

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo H&R Block Inc.

HRB

H&R Block Inc.

HOLD

Current Price

$31.25

Market Cap

4.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
HRB
Founded
2015
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
4.1B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
PRAX
HRB
Price
$305.30
$31.25
Analyst Decision
Strong Buy
Sell
Analyst Count
15
2
Target Price
$572.13
$41.00
AVG Volume (30 Days)
306.4K
2.2M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
5.35%
EPS Growth
N/A
6.55
EPS
N/A
4.39
Revenue
N/A
$3,159,931,000.00
Revenue This Year
N/A
$4.39
Revenue Next Year
$6,395.88
$3.21
P/E Ratio
N/A
$7.14
Revenue Growth
N/A
N/A
52 Week Low
$26.70
$28.16
52 Week High
$354.87
$64.62

Technical Indicators

Market Signals
Indicator
PRAX
HRB
Relative Strength Index (RSI) 44.70 45.46
Support Level $290.36 $28.68
Resistance Level $322.32 $32.65
Average True Range (ATR) 16.80 1.08
MACD -3.69 0.36
Stochastic Oscillator 25.12 55.27

Price Performance

Historical Comparison
PRAX
HRB

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About HRB H&R Block Inc.

H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.

Share on Social Networks: